IL13 and airway hyperresponsiveness: On the contrary, in mice receiving intranasal exposure of high-dose HDM at early time points and multiple treatments of low-dose HDM at later time points, HRV triggers both type 1 and type 2 responses including IL-4 and IL-13 expression, eosinophilic inflammation and airway hyperresponsiveness [48,49,50,131].